Hefei Lifeon Pharmaceutical Co., Ltd. (003020.SZ)
CNY 30.83
(-3.63%)
CNY 30.83
(-3.63%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 226.67 Million CNY | 8.33% |
| 2022 | 209.24 Million CNY | 21.5% |
| 2021 | 172.22 Million CNY | 27.47% |
| 2020 | 135.11 Million CNY | 28.51% |
| 2019 | 105.14 Million CNY | 14.7% |
| 2018 | 91.66 Million CNY | 19.32% |
| 2017 | 76.81 Million CNY | 13.87% |
| 2016 | 67.46 Million CNY | 0.0% |
| 2014 | 53.82 Million CNY | 14.46% |
| 2013 | 47.02 Million CNY | 28.15% |
| 2012 | 36.69 Million CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q1 | 30.37 Million CNY | -45.07% |
| 2024 Q2 | 47.05 Million CNY | 54.94% |
| 2024 Q3 | 41.54 Million CNY | -11.71% |
| 2023 Q2 | 64.98 Million CNY | -1.74% |
| 2023 Q3 | 40.24 Million CNY | -38.07% |
| 2023 Q4 | 55.29 Million CNY | 37.4% |
| 2023 FY | 226.67 Million CNY | 8.33% |
| 2023 Q1 | 66.14 Million CNY | 69.34% |
| 2022 Q3 | 72.37 Million CNY | 41.8% |
| 2022 FY | 209.24 Million CNY | 21.5% |
| 2022 Q4 | 39.05 Million CNY | -46.04% |
| 2022 Q2 | 51.04 Million CNY | 8.31% |
| 2022 Q1 | 47.12 Million CNY | 0.52% |
| 2021 Q2 | 41.89 Million CNY | 0.48% |
| 2021 Q1 | 41.69 Million CNY | 17.59% |
| 2021 Q4 | 46.88 Million CNY | 12.28% |
| 2021 FY | 172.22 Million CNY | 27.47% |
| 2021 Q3 | 41.75 Million CNY | -0.32% |
| 2020 Q3 | 33.61 Million CNY | -9.17% |
| 2020 Q1 | 29.03 Million CNY | 2.93% |
| 2020 FY | 135.11 Million CNY | 28.51% |
| 2020 Q2 | 37.01 Million CNY | 27.47% |
| 2020 Q4 | 35.45 Million CNY | 5.47% |
| 2019 Q2 | 25.41 Million CNY | 0.0% |
| 2019 FY | 105.14 Million CNY | 14.7% |
| 2019 Q4 | 28.2 Million CNY | 8.07% |
| 2019 Q3 | 26.1 Million CNY | 2.71% |
| 2019 Q1 | 25.41 Million CNY | 0.0% |
| 2018 FY | 91.66 Million CNY | 19.32% |
| 2017 FY | 76.81 Million CNY | 13.87% |
| 2016 FY | 67.46 Million CNY | 0.0% |
| 2014 FY | 53.82 Million CNY | 14.46% |
| 2013 FY | 47.02 Million CNY | 28.15% |
| 2012 FY | 36.69 Million CNY | 0.0% |